CLARK DANIEL GRANT enters KIROMIC BIOPHARMA, INC. with 36.38K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/14/2021ACC: 0001104659-21-126323
Officer· Interim CFO
Since Sep 2021
36.38K
Baseline shares
100% direct
36.38K
Direct ownership
2 positions
5.15K
Derivative underlying
1 instrument
2
Security positions
All direct
Non-Derivative Holdings2
Common Stock
DirectShares owned6.87K
Restricted Stock Units
DirectShares owned29.52K
Total
36.38K direct36.38K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.87K | Direct |
| Restricted Stock Units | 29.52K | Direct |
| Total | 36.38K | 36.38K direct |
Derivative Holdings1
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
5.15K
Shares owned
N/A
Exercise price
17.47
Expiration
—
Exercise window
—
Total
Underlying
5.15K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 17.47 | — | — | 5.15K | N/A |
| Total | 5.15K | 0.00 | ||||